{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:40:10Z","timestamp":1792680010321,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T00:00:00Z","timestamp":1455580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["tcmonline.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.tcm.2016.01.003","type":"journal-article","created":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T18:45:52Z","timestamp":1454006752000},"page":"395-404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Stem cell therapy for heart failure: Ensuring regenerative proficiency"],"prefix":"10.1016","volume":"26","author":[{"given":"Andre","family":"Terzic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atta","family":"Behfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2016.01.003_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tcm.2014.05.005","article-title":"The ten advances that have defined modern cardiology","volume":"24","author":"Braunwald","year":"2014","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.tcm.2016.01.003_bib2","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1208200","article-title":"Door-to-balloon time and mortality among patients undergoing primary PCI","volume":"369","author":"Menees","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2016.01.003_bib3","first-page":"133","article-title":"Heart disease and stroke statistics\u20142016 update","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2016.01.003_bib4","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1161\/CIR.0000000000000065","article-title":"The heart failure paradox: an epidemic of scientific success","volume":"129","author":"Jessup","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2016.01.003_bib5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1752-8062.2011.00295.x","article-title":"Chronic diseases: the emerging pandemic","volume":"4","author":"Terzic","year":"2011","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.tcm.2016.01.003_bib6","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/ejhf.319","article-title":"Heart failure as a general pandemic in Asia","volume":"17","author":"Shimokawa","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.tcm.2016.01.003_bib7","doi-asserted-by":"crossref","first-page":"e000053","DOI":"10.1161\/JAHA.113.000053","article-title":"Improved survival after heart failure: a community-based perspective","volume":"2","author":"Joffe","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.tcm.2016.01.003_bib8","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.jacc.2015.02.032","article-title":"Evolving therapies for myocardial ischemia\/reperfusion injury","volume":"65","author":"Ib\u00e1\u00f1ez","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.01.003_bib9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs033","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.tcm.2016.01.003_bib10","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/ejhf.333","article-title":"In-hospital worsening heart failure","volume":"17","author":"Butler","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.tcm.2016.01.003_bib11","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0140-6736(14)61889-4","article-title":"The war against heart failure","volume":"385","author":"Braunwald","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2016.01.003_bib12","unstructured":"US Department of Health and Human Services. 2020: a new vision\u2014a future for regenerative medicine. http:\/\/medicine.osu.edu\/regenerativemedicine\/documents\/2020vision.pdf; [accessed 10.01.16]."},{"key":"10.1016\/j.tcm.2016.01.003_bib13","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.mayocp.2013.04.017","article-title":"Regenerative medicine primer","volume":"88","author":"Terzic","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.tcm.2016.01.003_bib14","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/jama.2015.1492","article-title":"Regenerative medicine","volume":"313","author":"Atala","year":"2015","journal-title":"J Am Med Assoc"},{"issue":"Suppl. 1","key":"10.1016\/j.tcm.2016.01.003_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1089\/scd.2013.0448","article-title":"Regenerative medicine blueprint","volume":"22","author":"Terzic","year":"2013","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.tcm.2016.01.003_bib16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.mayocp.2013.04.001","article-title":"Innate regeneration in the aging heart: healing from within","volume":"88","author":"Anversa","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.tcm.2016.01.003_bib17","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.cell.2015.05.026","article-title":"Dynamics of cell generation and turnover in the human heart","volume":"161","author":"Bergmann","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.tcm.2016.01.003_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehv596","article-title":"Repetition rescues regenerative reserve","author":"Behfar","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2016.01.003_bib19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jacc.2014.10.041","article-title":"Stem cells versus senescence: the yin and yang of cardiac health","volume":"65","author":"Behfar","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.01.003_bib20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature13193","article-title":"The role of senescent cells in ageing","volume":"509","author":"van Deursen","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tcm.2016.01.003_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/HCO.0000000000000138","article-title":"Stem cells in the management of advanced heart failure","volume":"30","author":"Menasch\u00e9","year":"2015","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.tcm.2016.01.003_bib22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.addr.2013.12.004","article-title":"Cell therapy, 3D culture systems and tissue engineering for cardiac regeneration","volume":"69\u201370","author":"Emmert","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.tcm.2016.01.003_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coche.2014.11.004","article-title":"Human cardiac tissue engineering: from pluripotent stem cells to heart repair","volume":"7","author":"Jackman","year":"2015","journal-title":"Curr Opin Chem Eng"},{"key":"10.1016\/j.tcm.2016.01.003_bib24","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nbt.2971","article-title":"An FDA perspective on pre-clinical development of cell-based regenerative medicine products","volume":"32","author":"Bailey","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.tcm.2016.01.003_bib25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.stem.2013.05.008","article-title":"Cardiac stem cell therapy and the promise of heart regeneration","volume":"12","author":"Garbern","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tcm.2016.01.003_bib26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.med.051508.215152","article-title":"Stem cells in the treatment of heart disease","volume":"61","author":"Janssens","year":"2010","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.tcm.2016.01.003_bib27","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/hrt.2007.139394","article-title":"Cells as biologics for cardiac repair in ischaemic heart failure","volume":"96","author":"Bartunek","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.tcm.2016.01.003_bib28","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/CIRCRESAHA.113.300219","article-title":"Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions","volume":"113","author":"Sanganalmath","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2016.01.003_bib29","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCRESAHA.116.303614","article-title":"Use of mesenchymal stem cells for therapy of cardiac disease","volume":"116","author":"Karantalis","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2016.01.003_bib30","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/CIRCRESAHA.115.306330","article-title":"Cardiac cell therapy: lost in meta-analyses","volume":"116","author":"Assmus","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2016.01.003_bib31","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1161\/CIRCRESAHA.116.304386","article-title":"Meta-analysis of cell therapy trials for patients with heart failure","volume":"116","author":"Fisher","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2016.01.003_bib32","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nrcardio.2014.9","article-title":"Cell therapy for cardiac repair\u2014lessons from clinical trials","volume":"11","author":"Behfar","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.tcm.2016.01.003_bib33","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.5966\/sctm.2015-0275","article-title":"Regenerative medicine build-out","volume":"4","author":"Terzic","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.tcm.2016.01.003_bib34","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nm.3627","article-title":"Translational strategies and challenges in regenerative medicine","volume":"20","author":"Dimmeler","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.tcm.2016.01.003_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stem.2015.06.007","article-title":"Stem cell therapies in clinical trials: progress and challenges","volume":"17","author":"Trounson","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tcm.2016.01.003_bib36","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/CIRCRESAHA.115.304353","article-title":"Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes","volume":"115","author":"Cogle","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2016.01.003_bib37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ejhf.422","article-title":"Cell-based therapies for cardiac repair\u2014a meeting report on scientific observations and European regulatory viewpoints","volume":"18","author":"Sch\u00fcssler-Lenz","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.tcm.2016.01.003_bib38","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJMe068172","article-title":"Cardiac cell therapy\u2014mixed results from mixed cells","volume":"355","author":"Rosenzweig","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2016.01.003_bib39","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1001\/jama.2012.64751","article-title":"Mixed results for bone marrow-derived cell therapy for ischemic heart disease","volume":"308","author":"Marb\u00e1n","year":"2012","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.tcm.2016.01.003_bib40","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jacc.2010.03.066","article-title":"Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction","volume":"56","author":"Behfar","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.01.003_bib41","series-title":"Stem cell and gene therapy for cardiovascular disease","first-page":"235","article-title":"Cardiopoietic stem cells for heart failure therapy","author":"Behfar","year":"2016"},{"key":"10.1016\/j.tcm.2016.01.003_bib42","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/eurheartj\/ehu117","article-title":"Regenerative heart failure therapy headed for optimization","volume":"35","author":"Terzic","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2016.01.003_bib43","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/jama.2013.3527","article-title":"Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial","volume":"309","author":"Assmus","year":"2013","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.tcm.2016.01.003_bib44","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jacc.2013.08.724","article-title":"Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS Trial (cardiosphere-derived autologous stem cells to reverse ventricular dysfunction)","volume":"63","author":"Malliaras","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.01.003_bib45","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.jacc.2015.08.879","article-title":"Synergistic effects of combined cell therapy for chronic ischemic cardiomyopathy","volume":"66","author":"Karantalis","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.01.003_bib46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCULATIONAHA.112.153973","article-title":"Stem cells and myocardial regeneration: cooperation wins over competition","volume":"127","author":"Leri","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2016.01.003_bib47","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.yjmcc.2008.09.122","article-title":"Guided stem cell cardiopoiesis: discovery and translation","volume":"45","author":"Behfar","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.tcm.2016.01.003_bib48","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1084\/jem.20061916","article-title":"Cardiopoietic programming of embryonic stem cells for tumor-free heart repair","volume":"204","author":"Behfar","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.tcm.2016.01.003_bib49","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1101\/gad.2018411","article-title":"Cardiac muscle regeneration: lessons from development","volume":"25","author":"Mercola","year":"2011","journal-title":"Genes Dev"},{"key":"10.1016\/j.tcm.2016.01.003_bib50","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1161\/CIRCRESAHA.112.270272","article-title":"A Nodal-to-TGF\u03b2 cascade exerts biphasic control over cardiopoiesis","volume":"111","author":"Cai","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2016.01.003_bib51","doi-asserted-by":"crossref","first-page":"R6","DOI":"10.1186\/gb-2008-9-1-r6","article-title":"Genomic chart guiding embryonic stem cell cardiopoiesis","volume":"9","author":"Faustino","year":"2008","journal-title":"Genome Biol"},{"key":"10.1016\/j.tcm.2016.01.003_bib52","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1634\/stemcells.2007-0599","article-title":"Cardioinductive network guiding stem cell differentiation revealed by proteomic cartography of tumor necrosis factor alpha-primed endodermal secretome","volume":"26","author":"Arrell","year":"2008","journal-title":"Stem Cells"},{"issue":"Suppl. 1","key":"10.1016\/j.tcm.2016.01.003_bib53","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1038\/ncpcardio0429","article-title":"Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny","volume":"3","author":"Behfar","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.tcm.2016.01.003_bib54","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1752-8062.2008.00024.x","article-title":"Mesenchymal stem cells: engineering regeneration","volume":"1","author":"Behfar","year":"2008","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.tcm.2016.01.003_bib55","doi-asserted-by":"crossref","first-page":"20140373","DOI":"10.1098\/rstb.2014.0373","article-title":"Stem cells for the treatment of heart failure","volume":"370","author":"Menasch\u00e9","year":"2015","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.tcm.2016.01.003_bib56","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1161\/CIRCRESAHA.114.305075","article-title":"Stem cell in the rough: repair quotient mined out of a bone marrow niche","volume":"115","author":"Behfar","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2016.01.003_bib57","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jacc.2010.02.064","article-title":"Boot camp for mesenchymal stem cells","volume":"56","author":"Marban","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.01.003_bib58","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2217\/bmm.15.31","article-title":"Cardiopoietic index predicts heart repair fitness of patient-derived stem cells","volume":"9","author":"Crespo-Diaz","year":"2015","journal-title":"Biomark Med"},{"key":"10.1016\/j.tcm.2016.01.003_bib59","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jacc.2014.09.086","article-title":"Nucleostemin rejuvenates cardiac progenitor cells and antagonizes myocardial aging","volume":"65","author":"Hariharan","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.01.003_bib60","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/clpt.2008.146","article-title":"Stem cells: biologics for regeneration","volume":"84","author":"Nelson","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.tcm.2016.01.003_bib61","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13287-015-0145-7","article-title":"Translating stem cell research to the clinic: a primer on translational considerations for your first stem cell protocol","volume":"6","author":"O\u2019Brien","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.tcm.2016.01.003_bib62","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2013.02.071","article-title":"Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics","volume":"61","author":"Bartunek","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.01.003_bib63","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/clpt.2008.295","article-title":"Delivery of biologics in cardiovascular regenerative medicine","volume":"85","author":"Bartunek","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.tcm.2016.01.003_bib64","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1016\/j.jacc.2013.03.028","article-title":"Cardiopoietry in motion: primed mesenchymal stem cells for ischemic cardiomyopathy","volume":"61","author":"Murry","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.01.003_bib65","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ejhf.434","article-title":"Congestive heart failure cardiopoietic regenerative therapy (CHART-1) trial design","volume":"18","author":"Bartunek","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.tcm.2016.01.003_bib66","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/CIRCINTERVENTIONS.112.000422","article-title":"Optimized delivery system achieves enhanced endomyocardial stem cell retention","volume":"6","author":"Behfar","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2016.01.003_bib67","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nbt0113-5","article-title":"Cardiac stem cell therapies inch toward clinical litmus test","volume":"31","author":"Sheridan","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.tcm.2016.01.003_bib68","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jchf.2015.04.011","article-title":"\u201cTargeting the Heart\u201d in heart failure: myocardial recovery in heart failure with reduced ejection fraction","volume":"3","author":"Wilcox","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.tcm.2016.01.003_bib69","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1152\/japplphysiol.00647.2007","article-title":"Aging and cardioprotection","volume":"103","author":"Jahangir","year":"2007","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.tcm.2016.01.003_bib70","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4252\/wjsc.v7.i2.352","article-title":"\u201cSecond-generation\u201d stem cells for cardiac repair","volume":"7","author":"N\u00fa\u00f1ez Garc\u00eda","year":"2015","journal-title":"World J Stem Cells"},{"key":"10.1016\/j.tcm.2016.01.003_bib71","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nm.3653","article-title":"Preparing the ground for tissue regeneration: from mechanism to therapy","volume":"20","author":"Forbes","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.tcm.2016.01.003_bib72","series-title":"Translational approach to heart failure","first-page":"449","article-title":"Stem cell therapy for ischemic heart disease","author":"Behfar","year":"2013"},{"key":"10.1016\/j.tcm.2016.01.003_bib73","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/ejhf.262","article-title":"International registry to assess medical practice with longitudinal observation for treatment of heart failure (REPORT-HF): rationale for and design of a global registry","volume":"17","author":"Filippatos","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.tcm.2016.01.003_bib74","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ejhf.479","article-title":"Clinical development plan for regenerative therapy in heart failure","volume":"18","author":"Terzic","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.tcm.2016.01.003_bib75","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1001\/jama.2015.15818","article-title":"Engaging patients across the spectrum of medical product development: view from the US Food and Drug Administration","volume":"314","author":"Hunter","year":"2015","journal-title":"J Am Med Assoc"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173816000219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173816000219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T14:46:13Z","timestamp":1600094773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173816000219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1050173816000219"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2016.01.003","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stem cell therapy for heart failure: Ensuring regenerative proficiency","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2016.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}